Stay updated on Safety of DCC-2618 in Advanced Malignancies Clinical Trial

Sign up to get notified when there's something new on the Safety of DCC-2618 in Advanced Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of DCC-2618 in Advanced Malignancies Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov record for the completed Phase 1 DCC-2618 (ripretinib) study is now displayed, with its study design, eligibility criteria, treatment cohorts, locations, and outcome measures.
    Difference
    84%
    Check dated 2026-11-09T12:58:26.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0; the study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T12:37:52.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces updates during a terminology transition, including use of “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T12:18:31.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site revision changed from v3.7.1 to v3.7.2, while the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T13:20:36.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T14:36:14.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The 403 error page snippet and the Home link were removed, indicating the page no longer displays the 403 Forbidden state and now shows the standard site layout.
    Difference
    0.5%
    Check dated 2026-09-28T16:56:09.000Z thumbnail image

Stay in the know with updates to Safety of DCC-2618 in Advanced Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of DCC-2618 in Advanced Malignancies Clinical Trial page.